From the aDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA
bDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA
cDepartment of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA
dDepartment of Pediatrics, Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, TN
eDepartment of Pediatrics, UPMC Children’s Hospital of Pittsburgh, Pittsburgh, PA
fDepartment of Pediatrics, Seattle Children’s Research Institute, Seattle Children’s Hospital and the University of Washington, Seattle, WA
gUniversity of Rochester School of Medicine and Dentistry, Rochester, NY
hUniversity of California at Los Angeles, Los Angeles, CA
iDepartment of Pediatrics, University of Cincinnati, Division of Infectious Diseases, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
jDepartment of Pediatrics, Baylor College of Medicine, Houston, TX
kTexas Children’s Hospital, Houston, TX
lChildren’s Mercy—Kansas City, Kansas City, MO
mUniversity of California—San Francisco Benioff Children’s Hospital Oakland, Oakland, CA
nPediatric Infectious Diseases, Stanford University School of Medicine, Stanford, CA.
Submitted August 26, 2021; accepted May 6, 2022
Data collection was supported by cooperative agreements with the Centers for Disease Control and Prevention (support award numbers 1UO1IP000458-01, 1UO1IP000459-01, 1UO1IP000464-01, 1UO1IP000460-01, 1UO1IP000457-01, 1UO1IP000461-01, 1UO1IP000463-01, 3UO1IP001059-01S1, 3UO1IP001049-01S1, 3UO1IP001063-01S1, 3UO1IP001057-01S1, 3UO1IP001050-01S1, 3UO1IP001054-01S1, 3UO1IP001051-01S1).
Disclosure: J.A.E. has research support from Merck, Pfizer, and GlaxoSmithKline and consults for Sanofi Pasteur and Meissa Vaccines. G.A.W. received an honorarium from Merck for authorship of chapters in the Merck Manual. M.M.M. has laboratory agreements with Merck Sharp & Dohme and Sanofi. C.J.H. has research support from Merck, GlaxoSmithKline, Pfizer, and Astra-Zeneca and has received honoraria from Frontline Medical Communications for contributions to Pediatric News. J.E.S. has research support from Merck. T.L.L. is a member of the Amgen Methods Advisory Council, for which he receives consulting fees and travel support. B.A.L. reports grants and personal fees from Takeda Pharmaceuticals and personal fees from World Health Organization, outside the subject of the submitted work. The other authors report no conflicts of interest.
The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.
Replication code will be made available on a GitHub repository. Data are not publicly available as New Vaccine Surveillance Network data are not part of CDC public-use datasets.
Supplemental digital content is available through direct URL citations in the HTML and PDF versions of this article (www.epidem.com).
Correspondence: Avnika B. Amin, Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA. E-mail: [email protected].
